kentucky semaglutide constipation lawsuit glp-1 Risks of Ozempic, other GLP-1 drugs are at center of sweeping lawsuit that kicked off in Philadelphia GLP-1 Overdose & Pharmaceutical Negligence

A city in the South, not New York or Los Angeles, has the highest per capita prescriptions of the popular weight loss drug.

Learn simple, effective tips to ease side effects and stay on track with your weight loss.

Both compounds belong to the growing class of incretin-based weight loss medications that target GLP-1, GIP, and glucagon receptors to help patients lose weight, improve blood sugar control, and reduce liver fat

Novo Nordisk and Ascendis Pharma have partnered to develop a long-acting, monthly GLP-1 drug

Treatment with semaglutide and tirzepatide led to significant weight loss and improved blood sugar control in overweight or obese patients with type 1 diabetes (T1D)